| Tier | Indication | Admitted to transplant center hospital |
| 1 | VA-ECMO | ✓ |
| Non-dischargeable, surgically implanted, non-endovascular biventricular support device | ✓ | |
| MCSD with life threatening ventricular arrhythmia | ✓ | |
| 2 | Non-dischargeable, surgically implanted, non-endovascular LVAD | ✓ |
| TAH, BiVAD, RVAD, or VAD for single ventricle patients | ||
| MCSD with malfunction | ✓ | |
| Percutaneous endovascular MCSD | ✓ | |
| IABP | ✓ | |
| VT or VF | ✓ | |
| 3 | Dischargeable LVAD for discretionary 30 days | |
| Multiple inotropes or a single high-dose inotrope and hemodynamic monitoring | ✓ | |
| MCSD with hemolysis | ||
| MCSD with pump thrombosis | ||
| MCSD with right heart failure | ||
| MCSD with device infection | ||
| MCSD with mucosal bleeding | ✓ | |
| MCSD with AI | ||
| VA-ECMO after 7 days | ✓ | |
| Non-dischargeable, surgically implanted, non-endovascular LVAD after 14 days | ✓ | |
| Percutaneous endovascular circulatory support device after 14 days | ✓ | |
| IABP after 14 days | ✓ | |
| 4 | Dischargeable LVAD without discretionary 30 days | |
| Inotropes without hemodynamic monitoring | ||
| Congenital heart disease | ||
| Ischemic heart disease with intractable angina | ||
| Amyloidosis, or hypertrophic or restrictive cardiomyopathy | ||
| Heart re-transplant | ||
| 5 | On the waitlist for at least one other organ at the same hospital | |
| 6 | Adult candidate suitable for transplant | |
| 7 | Patient is inactive |
